bitcoin
bitcoin

$98329.357093 USD

-0.02%

ethereum
ethereum

$3654.423759 USD

1.10%

xrp
xrp

$2.420984 USD

-1.43%

tether
tether

$0.999896 USD

0.03%

solana
solana

$215.855341 USD

-0.14%

bnb
bnb

$712.765926 USD

-0.15%

dogecoin
dogecoin

$0.390645 USD

1.26%

usd-coin
usd-coin

$0.999994 USD

0.00%

cardano
cardano

$1.074671 USD

-1.14%

tron
tron

$0.269515 USD

-0.06%

avalanche
avalanche

$42.789011 USD

2.21%

sui
sui

$5.292697 USD

8.73%

chainlink
chainlink

$23.749684 USD

1.32%

toncoin
toncoin

$5.740754 USD

-1.12%

shiba-inu
shiba-inu

$0.000024 USD

-1.09%

加密貨幣新聞文章

HOOKIPA Pharma Inc. 和 Poolbeg Pharma (POLB) 可能合併創建臨床階段生物製藥公司,專注於創新藥物的開發和商業化

2025/01/02 17:51

HOOKIPA Pharma Inc. 和 Poolbeg Pharma (POLB) 董事會宣布,他們已進入不具約束力的討論

HOOKIPA Pharma Inc. 和 Poolbeg Pharma (POLB) 可能合併創建臨床階段生物製藥公司,專注於創新藥物的開發和商業化

HOOKIPA Pharma (NASDAQ: HOOK) and Poolbeg Pharma (POLB) (NASDAQ: POLB) boards announced they have entered into non-binding discussions for an all-share acquisition by HOOKIPA of Poolbeg to create a clinical-stage biopharmaceutical company.

HOOKIPA Pharma(納斯達克股票代碼:HOOK)和Poolbeg Pharma (POLB)(納斯達克股票代碼:POLB)董事會宣布,他們已就HOOKIPA 收購Poolbeg 的全部股份以創建一家臨床階段的生物製藥公司進行不具約束力的討論。

The combined entity will be focused on developing and commercialising innovative medicines for critical unmet medical needs, with a special focus on next-generation immunotherapies for the treatment of cancer and other serious diseases.

合併後的實體將專注於開發和商業化創新藥物,以滿足關鍵的未滿足的醫療需求,特別關注用於治療癌症和其他嚴重疾病的下一代免疫療法。

In connection with the Potential Combination, HOOKIPA is expected to undertake a 100% primary private placement fundraise of up to approximately $30 million, which will be funded into HOOKIPA immediately following the completion of the Potential Combination.

關於潛在合併,HOOKIPA 預計將進行高達約 3,000 萬美元的 100% 主要私募融資,這筆資金將在潛在合併完成後立即註入 HOOKIPA。

The proceeds from the private placement will be used to provide sufficient capital for the enlarged business to realise meaningful expected value inflection points.

私募所得款項將用於為擴大後的業務提供充足的資金,以實現有意義的預期價值轉折點。

Coinsilium Group (COIN) (AQUIS: COIN), the Web3 investor, advisor, and venture builder, has entered into a strategic collaboration agreement with investment portfolio company Otomato Inc, a pioneering Web3 technology platform specialising in autonomous agent-based solutions.

Web3 投資者、顧問和風險創建者 Coinsilium Group (COIN)(AQUIS:COIN)已與投資組合公司 Otomato Inc 簽訂策略合作協議,Otomato Inc 是一家專注於基於自主代理的解決方案的領先 Web3 技術平台。

The Collaboration aims to leverage Otomato’s cutting edge technologies to maximise the return potential of Coinsilium’s existing and future digital asset treasury holdings.

此次合作旨在利用 Otomato 的尖端技術,最大限度地提高 Coinsilium 現有和未來數位資產庫存的回報潛力。

Given that the market is currently shining a light on COIN, and crypto, it makes sense for it to press ahead on an area which arguably will be the picks and shovels of what will happen next in the digital space: Web3.

鑑於市場目前對 COIN 和加密貨幣的關注度很高,因此推進一個可以說是數位空間接下來將發生的事情的領域:Web3 是有意義的。

Quadrise (QED), a supplier of innovative energy solutions for a cleaner planet, announced the signature of an agreement between the European Climate, Infrastructure and Environment Executive Agency and SEASTARS, a consortium of 17 companies which includes Quadrise.

Quadrise (QED) 是一家為清潔地球提供創新能源解決方案的供應商,宣布歐洲氣候、基礎設施和環境執行機構與 SEASTARS 簽署協議。

QED said it was delighted to have joined the SEASTARS consortium, which will demonstrate the benefits of bioMSAR™ and our Blend-On-Board technology to a much wider audience, whilst our participation in the Horizon project will deepen our combined knowledge in this important area of marine decarbonisation.

QED 表示很高興加入 SEASTARS 聯盟,該聯盟將向更廣泛的受眾展示 bioMSAR™ 和我們的 Blend-On-Board 技術的優勢,同時我們參與 Horizo​​n 專案將加深我們在這一重要領域的綜合知識海洋脫碳。

Although something of a filler RNS, QED is nevertheless reminding us that this autumn was transformational for the company both fundamentally and in terms of the share price, and that the momentum is set to continue.

儘管 QED 有點像 RNS 的填充物,但它仍然提醒我們,今年秋天對公司來說無論是基本面還是股價都發生了轉變,而且這種勢頭將持續下去。

Contango Holdings (CGO), a company focused on unlocking value from the +2 billion tonne Muchesu coal project in Zimbabwe, has confirmed it has now received its first royalty payment of US$200,000 and expects to receive a further US$800,000 this month.

Contango Holdings (CGO) 是一家致力於釋放津巴布韋超過20 億噸的Muchesu 煤炭項目價值的公司,該公司已確認現已收到第一筆20 萬美元的特許權使用費,並預計本月將進一步收到80 萬美元。

Combined these will bring total royalty receipts to US$1,000,000 as envisaged and previously reported under the Mineral Royalty Agreement.

這些合計將使特許權使用費收入總額達到 1,000,000 美元,正如《礦產特許權使用費協議》中所設想和先前報告的那樣。

CGO said this milestone marks a significant step forward in unlocking the immense value of the Muchesu coal project.

CGO表示,這一里程碑標誌著在釋放穆切蘇煤炭計畫巨大價值方面向前邁出了重要一步。

The receipt of our first royalty payment not only underscores the confidence our partners have in the project’s potential but also reinforces our commitment to delivering consistent value for our shareholders. With the operational foundations now firmly in place, we are excited about the continued progress and growth opportunities ahead.

我們收到第一筆特許權使用費不僅強調了我們的合作夥伴對該專案潛力的信心,而且強化了我們為股東提供一致價值的承諾。隨著營運基礎現已牢固就位,我們對未來的持續進步和成長機會感到興奮。

Celadon Pharmaceuticals (CEL), a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines, has updated on its financial position.

Celadon Pharmaceuticals (CEL) 是一家總部位於英國的製藥公司,專注於突破性大麻藥物的開發、生產和銷售,該公司更新了其財務狀況。

The Company can confirmed the provider of the Committed Credit Facility has now transferred an additional £147k under the Company £1m draw down request.

公司可以確認承諾信貸融資的提供者現已根據公司 100 萬英鎊的提款請求額外轉移了 14.7 萬英鎊。

The Company expects to receive the remaining £103k that is outstanding under the draw down during January 2025.

該公司預計將在 2025 年 1 月期間收到未提取的剩餘 10.3 萬英鎊。

While we know from Tesco that “Every Little Helps”, what we do not quite know is how CEL’s dribs and drabs will payments help its overall situation, or whether this is too little too late?

雖然我們從Tesco那裡知道“一點一滴都有幫助”,但我們不太清楚光大控股的點點滴滴的付款將如何幫助其整體狀況,或者這是否太少太晚了?

To directly support and accelerate the Company’s global licensing and partnership strategy to bring its non-invasive, cost effective, CIZ1B biomarker lung cancer blood test to market in 2025, Cizzle Biotechnology (CIZ), the UK based diagnostics developer, has announced that Professor Dawn Coverley, Founder and Non-Executive Director of Cizzle Biotechnology has, with immediate effect, been appointed Chief Scientific Officer, an executive role on the board of the Company.

為了直接支持和加速公司的全球許可和合作夥伴策略,以便於2025 年將其非侵入性、成本效益高的CIZ1B 生物標誌物肺癌血液檢測推向市場,英國診斷開發商Cizzle Biotechnology (CIZ) 宣布, Dawn 教授Cizzle Biotechnology 創辦人兼非執行董事 Coverley 已被任命為首席科學官,即公司董事會的執行職務,立即生效。

While we congratulate the professor on her new role, the main thing that the company has needed since it came to market is an evangelist for the cause, to explain to the market the investment proposition and the importance of what it is doing. Only then will CIZ attain a serious valuation.

雖然我們祝賀這位教授的新角色,但該公司自進入市場以來最需要的是宣傳者,向市場解釋投資主張及其正在做的事情的重要性。只有這樣,CIZ 才會獲得嚴肅的估值。

Emmerson (EML), the Moroccan focused potash development company, has announced that it has signed a Capital Provision Agreement with a specialist litigation funding firm to provide up to US$11,000,000 in both litigation finance capital and working capital for the Company (the “Funding”) and has confirmed Boies Schiller Flexner LLP as its litigation counsel.

專注於摩洛哥鉀肥開發的公司艾默生 (EML) 宣布,已與一家專業訴訟融資公司簽署了一份資本撥備協議,為公司提供最多 11,000,000 美元的訴訟融資資本和營運資本(“資金”) )並已確認Boies Schiller Flexner LLP 為其訴訟律師。

The Company has also put a Management Incentive Plan into place.

公司也制定了管理層激勵計劃。

After allegedly getting ripped

據稱被撕毀後

新聞來源:www.share-talk.com

免責聲明:info@kdj.com

The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!

If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.

2025年01月05日 其他文章發表於